{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:36:02Z","timestamp":1789605362578,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bj.2022.07.008","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T10:02:10Z","timestamp":1659866530000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection"],"prefix":"10.1016","volume":"46","author":[{"given":"Maia Lina","family":"Elizagaray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mazitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pontoriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Docena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Correger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9041-6808","authenticated-orcid":false,"given":"Martin","family":"Rumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chest.2020.04.010","article-title":"Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China","volume":"158","author":"Chen","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.bj.2022.07.008_bib2","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.gloepi.2021.100068","article-title":"Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020","volume":"3","author":"Ayoub","year":"2021","journal-title":"Glob Epidemiol"},{"issue":"25","key":"10.1016\/j.bj.2022.07.008_bib3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N Engl J Med"},{"issue":"6490","key":"10.1016\/j.bj.2022.07.008_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bj.2022.07.008_bib5","doi-asserted-by":"crossref","first-page":"635560","DOI":"10.3389\/fmed.2021.635560","article-title":"Mortality and clinical interventions in critically ill patient with coronavirus disease 2019: a systematic review and meta-analysis","volume":"8","author":"Qian","year":"2021","journal-title":"Front Med"},{"issue":"9","key":"10.1016\/j.bj.2022.07.008_bib6","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41366-021-00872-9","article-title":"Obesity and mortality in critically ill COVID-19 patients with respiratory failure","volume":"45","author":"Dana","year":"2021","journal-title":"Int J Obes"},{"issue":"10288","key":"10.1016\/j.bj.2022.07.008_bib7","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(21)00441-4","article-title":"Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study","volume":"397","author":"Biccard","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2022.07.008_bib8","doi-asserted-by":"crossref","first-page":"100243","DOI":"10.1016\/j.lanepe.2021.100243","article-title":"Mortality comparison between the first and second\/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: a multicentre retrospective cohort study","volume":"11","author":"Carbonell","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.bj.2022.07.008_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bj.2022.07.008_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOH.0000000000000666","article-title":"Mechanisms of immunothrombosis in COVID-19","volume":"28","author":"Portier","year":"2021","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.bj.2022.07.008_bib11","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.bj.2022.07.008_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41587-020-0634-9","article-title":"Focus shifts to antibody cocktails for COVID-19 cytokine storm","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.bj.2022.07.008_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bj.2022.07.008_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000542-200410000-00015","article-title":"Local anesthetics reduce mortality and protect against renal and hepatic dysfunction in murine septic peritonitis","volume":"101","author":"Gallos","year":"2004","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.bj.2022.07.008_bib15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1213\/ANE.0b013e3181bab1bd","article-title":"The effect of perioperative intravenous lidocaine on postoperative pain and immune function","volume":"109","author":"Yardeni","year":"2009","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.bj.2022.07.008_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2165\/10898560-000000000-00000","article-title":"Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials","volume":"70","author":"McCarthy","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.bj.2022.07.008_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6630232","article-title":"Effect of intravenous lidocaine on inflammatory and apoptotic response of ischemia-reperfusion injury in pigs undergoing lung resection surgery","volume":"2021","author":"Romera","year":"2021","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.bj.2022.07.008_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2018.12.009","article-title":"Recombinant flagellins with deletions in domains D1, D2, and D3: characterization as novel immunoadjuvants","volume":"37","author":"Biedma","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.bj.2022.07.008_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bj.2022.07.008_bib20","doi-asserted-by":"crossref","first-page":"705080","DOI":"10.3389\/fimmu.2021.705080","article-title":"Targeting TLR4 signaling to blunt viral-mediated acute lung injury","volume":"12","author":"Shirey","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bj.2022.07.008_bib21","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jmv.26826","article-title":"Role of Toll-like receptors in the pathogenesis of COVID-19","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.bj.2022.07.008_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"issue":"7821","key":"10.1016\/j.bj.2022.07.008_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bj.2022.07.008_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.it.2021.02.003","article-title":"Dual nature of type I interferons in SARS-CoV-2-induced inflammation","volume":"42","author":"King","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bj.2022.07.008_bib26","doi-asserted-by":"crossref","first-page":"103642","DOI":"10.1016\/j.ebiom.2021.103642","article-title":"Off balance: interferons in COVID-19 lung infections","volume":"73","author":"Akamatsu","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bj.2022.07.008_bib27","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.bj.2022.07.008_bib28","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib29","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2666-5247(20)30008-2","article-title":"SARS-CoV-2 cellular tropism","volume":"1","author":"Cagno","year":"2020","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib30","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","volume":"1","author":"Chu","year":"2020","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.bj.2022.07.008_bib31","article-title":"Risk factors of SARS-CoV-2 infection: global epidemiological study","volume":"2","author":"Barletta","year":"2021","journal-title":"JMIRx Med"},{"key":"10.1016\/j.bj.2022.07.008_bib32","doi-asserted-by":"crossref","first-page":"106890","DOI":"10.1016\/j.ypmed.2021.106890","article-title":"Changes in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten months into the vaccination program: the Israeli case","volume":"154","author":"Saban","year":"2022","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.bj.2022.07.008_bib33","first-page":"E311","article-title":"Case fatality rate of COVID-19: a systematic review and meta-analysis","volume":"62","author":"Alimohamadi","year":"2021","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib34","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1080\/22221751.2021.2006579","article-title":"A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality","volume":"10","author":"Camelo","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s43440-021-00341-0","article-title":"Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial","volume":"74","author":"Toroghi","year":"2022","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib36","doi-asserted-by":"crossref","first-page":"2102532","DOI":"10.1183\/13993003.02532-2021","article-title":"Dexamethasone in hospitalised coronavirus-19 patients not on intensive respiratory support","volume":"60","author":"Crothers","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00134-021-06573-1","article-title":"Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial","volume":"48","author":"Granholm","year":"2022","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40121-021-00545-0","article-title":"Efficacy and safety of immunomodulators in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials","volume":"11","author":"Ngamprasertchai","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bj.2022.07.008_bib39","doi-asserted-by":"crossref","first-page":"155593","DOI":"10.1016\/j.cyto.2021.155593","article-title":"The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?","volume":"144","author":"Morris","year":"2021","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.bj.2022.07.008_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00540-021-02974-0","article-title":"Tocilizumab in patients with COVID-19: which patient, time, and dose?","volume":"35","author":"Hasanin","year":"2021","journal-title":"J Anesth"},{"issue":"9","key":"10.1016\/j.bj.2022.07.008_bib41","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/microorganisms9091820","article-title":"TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection","volume":"9","author":"Bortolotti","year":"2021","journal-title":"Microorganisms"},{"issue":"7-8","key":"10.1016\/j.bj.2022.07.008_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/17534259211051364","article-title":"TLRs in COVID-19: how they drive immunopathology and the rationale for modulation","volume":"27","author":"Mabrey","year":"2021","journal-title":"Innate Immun"},{"key":"10.1016\/j.bj.2022.07.008_bib43","doi-asserted-by":"crossref","first-page":"102733","DOI":"10.1016\/j.amsu.2021.102733","article-title":"Molecular mechanisms of lidocaine","volume":"69","author":"Karnina","year":"2021","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.bj.2022.07.008_bib44","doi-asserted-by":"crossref","first-page":"198171","DOI":"10.1016\/j.virusres.2020.198171","article-title":"IFN-\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection","volume":"289","author":"Gadotti","year":"2020","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib45","doi-asserted-by":"crossref","first-page":"22958","DOI":"10.1038\/s41598-021-02489-4","article-title":"Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome","volume":"11","author":"Masood","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bj.2022.07.008_bib46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.bj.2022.07.008_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/biology10090829","article-title":"Type I interferons in COVID-19 pathogenesis","volume":"10","author":"Palermo","year":"2021","journal-title":"Biology"},{"issue":"6","key":"10.1016\/j.bj.2022.07.008_bib48","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.hrtlng.2020.09.001","article-title":"Anti-inflammatory aspects of Lidocaine: a neglected therapeutic stance for COVID-19","volume":"49","author":"Maab","year":"2020","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.bj.2022.07.008_bib49","doi-asserted-by":"crossref","DOI":"10.4103\/joacp.JOACP_562_20","article-title":"Intravenous lidocaine infusion in a case of severe COVID-19 infection","volume":"37","author":"Rylova","year":"2021","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13063-021-05095-x","article-title":"Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): a structured summary of a study protocol for a randomised controlled trial","volume":"22","author":"Muller","year":"2021","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.bj.2022.07.008_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11302-021-09814-6","article-title":"A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling","volume":"18","author":"Hasan","year":"2022","journal-title":"Purinergic Signal"},{"issue":"2","key":"10.1016\/j.bj.2022.07.008_bib52","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2249.2008.03636.x","article-title":"Lidocaine down-regulates nuclear factor-\u03baB signalling and inhibits cytokine production and T cell proliferation","volume":"152","author":"Lahat","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bj.2022.07.008_bib53","doi-asserted-by":"crossref","first-page":"570370","DOI":"10.1155\/2013\/570370","article-title":"The protective effect of lidocaine on septic rats via the inhibition of high mobility group box 1 expression and NF-\u03baB activation","volume":"2013","author":"Wang","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.bj.2022.07.008_bib54","doi-asserted-by":"crossref","first-page":"106150","DOI":"10.1016\/j.intimp.2019.106150","article-title":"Lidocaine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxemia in mice by suppressing HIF1\u03b1-induced glycolysis","volume":"80","author":"Lin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bj.2022.07.008_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molimm.2021.04.007","article-title":"Attenuation of ventilator-induced lung injury through suppressing the pro-inflammatory signaling pathways: a review on preclinical studies","volume":"135","author":"Monjezi","year":"2021","journal-title":"Mol Immunol"},{"issue":"22","key":"10.1016\/j.bj.2022.07.008_bib56","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.3390\/ijms21228549","article-title":"Review: ischemia reperfusion injury-A translational perspective in organ transplantation","volume":"21","author":"Fern\u00e1ndez","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417022001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417022001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:12:33Z","timestamp":1762420353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417022001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2319417022001196"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2022.07.008","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2022.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}]}}